Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services

Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

The contract research organization market is projected to foresee commendable growth by 2027 owing to rising prevalence of cancer, increasing incidence of cardiovascular disorders, and the numerous clinical trials being conducted globally. A CRO or contract research organization, is an organization hired by a firm in the medical domain to essentially manage the its clinical trials and also conduct other related tasks so as to bring a device new or drug into the market.

While CROs mainly make contracts with companies that are active in the medical device, biotechnology, and pharmaceutical field, their customers also include universities, foundations, and governmental institutions.

Contract research organization’s play an essential role in all facets of the medical device or drug development process, right from early discovery to launch, focusing mainly on Phase I to III clinical trials.

The contract research organization market is bifurcated in terms of service type, therapeutic area, end-use and regional landscape.

Based on service type, the CRO market is classified into regulatory consulting services, laboratory services, clinical research services, and early phase development services. Among these, the regulatory consulting services segment accounted for $5.5 billion in 2020 and is anticipated to showcase a decent growth rate during the study period.

With respect to therapeutic area, the market for contract research organization is categorized into ophthalmology, gastroenterology & hepatology, neurology, infectious disease, cardiology, clinical pharmacology, oncology, and others. Among these, the cardiology segment is expected to reach a valuation of more than $2.6 billion by the end of 2027.

Increasing number of clinical trials and the rising prevalence of cardiovascular diseases across the globe would support the segmental growth during the forecast period.

In terms of end-use, the overall contract research organization is segmented into academic institutes, medical device companies, and pharmaceutical and biopharmaceutical companies. In 2020, the segment for pharmaceutical & biopharmaceutical enterprises accounted for a 55.2% market share. Industry outlooks are expecting the segment to see substantial growth over the coming time period.

On the regional front, in 2020, the contract research organization market in Latin America held a market share of 4.5% and anticipated to register similar growth patterns in the times to come.

Meanwhile, Middle East & Africa CRO market is expected to showcase steady growth of 6.8% during the analysis period. Increasing prevalence of cancer in Gulf countries, rising number of contract research organizations, and surging number of clinical trials will aid the regional market growth.

In fact, UAE is now becoming one of the prominent regional hubs for clinical trials, presenting more and more in Dubai regional as well as scientific offices of pharma companies and CROs offices.


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Contract research organization industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Service type trends
2.1.3 Therapeutic area trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Contract Research Organization Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing R&D expenditure worldwide
3.3.1.2 Growing number of clinical trials in emerging countries
3.3.1.3 Growing outsourcing of R&D activities
3.3.1.4 Rising technological advancements
3.3.2 Industry pitfalls & challenges
3.3.2.1 Intellectual property rights issues
3.3.2.2 Stringent regulatory policies
3.4 Growth potential analysis
3.4.1 By service type
3.4.2 By therapeutic area
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 Competitive landscape, 2020
3.8.1 Company matrix analysis
3.9 PESTEL analysis
Chapter 4 Contract Research Organization Market, By Service Type
4.1 Key segment trend
4.2 Early phase development services
4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.2 Discovery phase
4.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.3 Chemistry, manufacturing & control (CMC)
4.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.4 Preclinical services
4.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.4.2 Pharmacokinetic/Pharmacodynamic (PK/PD)
4.2.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.4.3 Toxicology testing services
4.2.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.2.4.4 Others
4.2.4.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.3 Clinical research services
4.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.3.2 Phase I
4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.3.3 Phase II
4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.3.4 Phase III
4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.3.5 Phase IV
4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
4.4 Laboratory services
4.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.2 Bioanalytical testing services
4.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3 Analytical testing services
4.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3.2 Physical characterization
4.4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3.3 Raw material testing
4.4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3.4 Stability testing
4.4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.4.3.5 Others
4.4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
4.5 Regulatory consulting services
4.5.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 Contract Research Organization Market, By Therapeutic Area
5.1 Key segment trend
5.2 Oncology
5.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.3 Clinical pharmacology
5.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.4 Cardiology
5.4.1 Market size, by region, 2016 - 2027 (USD Million)
5.5 Infectious disease
5.5.1 Market size, by region, 2016 - 2027 (USD Million)
5.6 Neurology
5.6.1 Market size, by region, 2016 - 2027 (USD Million)
5.7 Gastroenterology & hepatology
5.7.1 Market size, by region, 2016 - 2027 (USD Million)
5.8 Ophthalmology
5.8.1 Market size, by region, 2016 - 2027 (USD Million)
5.9 Others
5.9.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 Contract Research Organization Market, By End-use
6.1 Key segment trend
6.2 Pharmaceutical & biopharmaceutical companies
6.2.1 Market size, by region, 2016 - 2027 (USD Million)
6.3 Medical device companies
6.3.1 Market size, by region, 2016 - 2027 (USD Million)
6.4 Academic institutes
6.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 7 Contract Research Organization Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2016 - 2027 (USD Million)
7.2.2 Market size, by service type, 2016 - 2027 (USD Million)
7.2.2.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.2.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.2.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.2.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.2.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.2.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by service type, 2016 - 2027 (USD Million)
7.2.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.2.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.2.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.2.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.2.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.2.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by service type, 2016 - 2027 (USD Million)
7.2.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.2.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.2.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.2.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.2.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.2.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2016 - 2027 (USD Million)
7.3.2 Market size, by service type, 2016 - 2027 (USD Million)
7.3.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
7.3.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by service type, 2016 - 2027 (USD Million)
7.3.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.3.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by service type, 2016 - 2027 (USD Million)
7.3.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.3.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.7 France
7.3.7.1 Market size, by service type, 2016 - 2027 (USD Million)
7.3.7.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.3.7.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.7.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.7.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.7.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.7.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by service type, 2016 - 2027 (USD Million)
7.3.8.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.3.8.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.8.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.8.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.8.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.8.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.9 Italy
7.3.9.1 Market size, by service type, 2016 - 2027 (USD Million)
7.3.9.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.3.9.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.3.9.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.3.9.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.3.9.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.3.9.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2016 - 2027 (USD Million)
7.4.2 Market size, by service type, 2016 - 2027 (USD Million)
7.4.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
7.4.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.4.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.4.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.4.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.4.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.5 China
7.4.5.1 Market size, by service type, 2016 - 2027 (USD Million)
7.4.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.4.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.4.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.4.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.4.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.4.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.6 Japan
7.4.6.1 Market size, by service type, 2016 - 2027 (USD Million)
7.4.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.4.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.4.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.4.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.4.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.4.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.7 India
7.4.7.1 Market size, by service type, 2016 - 2027 (USD Million)
7.4.7.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.4.7.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.4.7.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.4.7.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.4.7.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.4.7.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2016 - 2027 (USD Million)
7.5.2 Market size, by service type, 2016 - 2027 (USD Million)
7.5.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
7.5.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.5.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.5.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.5.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by service type, 2016 - 2027 (USD Million)
7.5.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.5.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.5.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.5.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.5.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.5.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by service type, 2016 - 2027 (USD Million)
7.5.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.5.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.5.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.5.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.5.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.5.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2016 - 2027 (USD Million)
7.6.2 Market size, by service type, 2016 - 2027 (USD Million)
7.6.2.1 Market size, by early phase development, 2016 - 2027 (USD Million)
7.6.2.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.6.2.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.6.2.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.6.2.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by service type, 2016 - 2027 (USD Million)
7.6.5.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.6.5.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.6.5.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.6.5.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.6.5.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.6.5.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by service type, 2016 - 2027 (USD Million)
7.6.6.1.1 Market size, by early phase development services, 2016 - 2027 (USD Million)
7.6.6.1.1.1 Market size, by preclinical services, 2016 - 2027 (USD Million)
7.6.6.1.2 Market size, by clinical research services, 2016 - 2027 (USD Million)
7.6.6.1.3 Market size, by laboratory services, 2016 - 2027 (USD Million)
7.6.6.1.3.1 Market size, by analytical testing services, 2016 - 2027 (USD Million)
7.6.6.2 Market size, by therapeutic area, 2016 - 2027 (USD Million)
7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2020
8.2 Charles River Laboratories
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Clinicpace
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 CMIC Holding Co.,LTD
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 EPS International Co., Ltd
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 ICON plc
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 IQVIA
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Laboratory Corporation of American Holding (Covance Inc)
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Medpace, Inc
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Parexel International Corporation
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Pharmaceutical Product Development, LLC (PPD)
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 PRA Health Sciences
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Syneos Health
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Synteract
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
8.15 Worldwide Clinical Trials
8.15.1 Business overview
8.15.2 Financial data
8.15.3 Product landscape
8.15.4 Strategic outlook
8.15.5 SWOT analysis
8.16 WuXi AppTec
8.16.1 Business overview
8.16.2 Financial data
8.16.3 Product landscape
8.16.4 Strategic outlook
8.16.5 SWOT analysis
Data Tables
TABLE 1 CRO industry 360 degree synopsis, 2016 - 2027
TABLE 2 CRO market, 2016 - 2020 (USD Million)
TABLE 3 CRO market, 2021 - 2027 (USD Million)
TABLE 4 CRO market, by service type, 2016 - 2020 (USD Million)
TABLE 5 CRO market, by service type, 2021 - 2027 (USD Million)
TABLE 6 CRO market, by therapeutic area, 2016 - 2020 (USD Million)
TABLE 7 CRO market, by therapeutic area, 2021 - 2027 (USD Million)
TABLE 8 CRO market, by end-use, 2016 - 2020 (USD Million)
TABLE 9 CRO market, by end-use, 2021 - 2027 (USD Million)
TABLE 10 CRO market, by region, 2016 - 2020 (USD Million)
TABLE 11 CRO market, by region, 2021 - 2027 (USD Million)
TABLE 12 Industry impact forces
TABLE 13 Early phase development services market size, by region, 2016 - 2020 (USD Million)
TABLE 14 Early phase development services market size, by region, 2021 - 2027 (USD Million)
TABLE 15 Discovery services market size, by region, 2016 - 2020 (USD Million)
TABLE 16 Discovery services market size, by region, 2021 - 2027 (USD Million)
TABLE 17 CMC market size, by region, 2016 - 2020 (USD Million)
TABLE 18 CMC market size, by region, 2021 - 2027 (USD Million)
TABLE 19 Pre-clinical services market size, by region, 2016 - 2020 (USD Million)
TABLE 20 Pre-clinical services market size, by region, 2021 - 2027 (USD Million)
TABLE 21 PK/PD market size, by region, 2016 - 2020 (USD Million)
TABLE 22 PK/PD market size, by region, 2021 - 2027 (USD Million)
TABLE 23 Toxicology testing services market size, by region, 2016 - 2020 (USD Million)
TABLE 24 Toxicology testing services market size, by region, 2021 - 2027 (USD Million)
TABLE 25 Others market size, by region, 2016 - 2020 (USD Million)
TABLE 26 Others market size, by region, 2021 - 2027 (USD Million)
TABLE 27 Clinical research services market size, by region, 2016 - 2020 (USD Million)
TABLE 28 Clinical research services market size, by region, 2021 - 2027 (USD Million)
TABLE 29 Phase I market size, by region, 2016 - 2020 (USD Million)
TABLE 30 Phase I market size, by region, 2021 - 2027 (USD Million)
TABLE 31 Phase II market size, by region, 2016 - 2020 (USD Million)
TABLE 32 Phase II market size, by region, 2021 - 2027 (USD Million)
TABLE 33 Phase III market size, by region, 2016 - 2020 (USD Million)
TABLE 34 Phase III market size, by region, 2021 - 2027 (USD Million)
TABLE 35 Phase IV market size, by region, 2016 - 2020 (USD Million)
TABLE 36 Phase IV market size, by region, 2021 - 2027 (USD Million)
TABLE 37 Laboratory services market size, by region, 2016 - 2020 (USD Million)
TABLE 38 Laboratory services market size, by region, 2021 - 2027 (USD Million)
TABLE 39 Bioanalytical testing services market size, by region, 2016 - 2020 (USD Million)
TABLE 40 Bioanalytical testing services market size, by region, 2021 - 2027 (USD Million)
TABLE 41 Analytical testing services market size, by region, 2016 - 2020 (USD Million)
TABLE 42 Analytical testing services market size, by region, 2021 - 2027 (USD Million)
TABLE 43 Physical characterization market size, by region, 2016 - 2020 (USD Million)
TABLE 44 Physical characterization market size, by region, 2021 - 2027 (USD Million)
TABLE 45 Raw material testing market size, by region, 2016 - 2020 (USD Million)
TABLE 46 Raw material testing market size, by region, 2021 - 2027 (USD Million)
TABLE 47 Batch release testing market size, by region, 2016 - 2020 (USD Million)
TABLE 48 Batch release testing market size, by region, 2021 - 2027 (USD Million)
TABLE 49 Stability testing market size, by region, 2016 - 2020 (USD Million)
TABLE 50 Stability testing market size, by region, 2021 - 2027 (USD Million)
TABLE 51 Others market size, by region, 2016 - 2020 (USD Million)
TABLE 52 Others market size, by region, 2021 - 2027 (USD Million)
TABLE 53 Consulting services market size, by region, 2016 - 2020 (USD Million)
TABLE 54 Consulting services market size, by region, 2021 - 2027 (USD Million)
TABLE 55 Oncology market size, by region, 2016 - 2020 (USD Million)
TABLE 56 Oncology market size, by region, 2021 - 2027 (USD Million)
TABLE 57 Clinical pharmacology market size, by region, 2016 - 2020 (USD Million)
TABLE 58 Clinical pharmacology market size, by region, 2021 - 2027 (USD Million)
TABLE 59 Cardiology market size, by region, 2016 - 2020 (USD Million)
TABLE 60 Cardiology market size, by region, 2021 - 2027 (USD Million)
TABLE 61 Infectious disease market size, by region, 2016 - 2020 (USD Million)
TABLE 62 Infectious disease market size, by region, 2021 - 2027 (USD Million)
TABLE 63 Neurology market size, by region, 2016 - 2020 (USD Million)
TABLE 64 Neurology market size, by region, 2021 - 2027 (USD Million)
TABLE 65 Gastroenterology & hepatology market size, by region, 2016 - 2020 (USD Million)
TABLE 66 Gastroenterology & hepatology market size, by region, 2021 - 2027 (USD Million)
TABLE 67 Ophthalmology market size, by region, 2016 - 2020 (USD Million)
TABLE 68 Ophthalmology market size, by region, 2021 - 2027 (USD Million)
TABLE 69 Others market size, by region, 2016 - 2020 (USD Million)
TABLE 70 Others market size, by region, 2021 - 2027 (USD Million)
TABLE 71 Pharmaceutical & biopharmaceutical companies market size, by region, 2016 - 2020 (USD Million)
TABLE 72 Pharmaceutical & biopharmaceutical companies market size, by region, 2021 - 2027 (USD Million)
TABLE 73 Medical device companies market size, by region, 2016 - 2020 (USD Million)
TABLE 74 Medical device companies market size, by region, 2021 - 2027 (USD Million)
TABLE 75 Academic institutes market size, by region, 2016 - 2020 (USD Million)
TABLE 76 Academic institutes market size, by region, 2021 - 2027 (USD Million)
TABLE 77 North America CRO market size, by country, 2016 - 2020 (USD Mn)
TABLE 78 North America CRO market size, by country, 2021 - 2027 (USD Mn)
TABLE 79 North America CRO market size, by service type, 2016 - 2020 (USD Mn)
TABLE 80 North America CRO market size, by service type, 2021 - 2027 (USD Mn)
TABLE 81 North America CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
TABLE 82 North America CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
TABLE 83 North America CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
TABLE 84 North America CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
TABLE 85 North America CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
TABLE 86 North America CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
TABLE 87 North America CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
TABLE 88 North America CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
TABLE 89 North America CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
TABLE 90 North America CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
TABLE 91 North America CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
TABLE 92 North America CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
TABLE 93 North America CRO market size, by end-use, 2016 - 2020 (USD Mn)
TABLE 94 North America CRO market size, by end-use, 2021 - 2027 (USD Mn)
TABLE 95 U.S. CRO market size, by service type, 2016 - 2020 (USD Mn)
TABLE 96 U.S. CRO market size, by service type, 2021 - 2027 (USD Mn)
TABLE 97 U.S. CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
TABLE 98 U.S. CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
TABLE 99 U.S. CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
TABLE 100 U.S. CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
TABLE 101 U.S. CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
TABLE 102 U.S. CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
TABLE 103 U.S. CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
TABLE 104 U.S. CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
TABLE 105 U.S. CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
TABLE 106 U.S. CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
TABLE 107 U.S. CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
TABLE 108 U.S. CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
TABLE 109 U.S. CRO market size, by end-use, 2016 - 2020 (USD Mn)
TABLE 110 U.S. CRO market size, by end-use, 2021 - 2027 (USD Mn)
TABLE 111 Canada CRO market size, by service type, 2016 - 2020 (USD Mn)
TABLE 112 Canada CRO market size, by service type, 2021 - 2027 (USD Mn)
TABLE 113 Canada CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
TABLE 114 Canada CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
TABLE 115 Canada CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
TABLE 116 Canada CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
TABLE 117 Canada CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
TABLE 118 Canada CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
TABLE 119 Canada CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
TABLE 120 Canada CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
TABLE 121 Canada CRO market size, by analytical testing services, 2016 - 2020 (USD Mn)
TABLE 122 Canada CRO market size, by analytical testing services, 2021 - 2027 (USD Mn)
TABLE 123 Canada CRO market size, by therapeutic area, 2016 - 2020 (USD Mn)
TABLE 124 Canada CRO market size, by therapeutic area, 2021 - 2027 (USD Mn)
TABLE 125 Canada CRO market size, by end-use, 2016 - 2020 (USD Mn)
TABLE 126 Canada CRO market size, by end-use, 2021 - 2027 (USD Mn)
TABLE 127 Europe CRO market size, by country, 2016 - 2020 (USD Mn)
TABLE 128 Europe CRO market size, by country, 2021 - 2027 (USD Mn)
TABLE 129 Europe CRO market size, by service type, 2016 - 2020 (USD Mn)
TABLE 130 Europe CRO market size, by service type, 2021 - 2027 (USD Mn)
TABLE 131 Europe CRO market size, by early phase development services, 2016 - 2020 (USD Mn)
TABLE 132 Europe CRO market size, by early phase development services, 2021 - 2027 (USD Mn)
TABLE 133 Europe CRO market size, by pre-clinical services, 2016 - 2020 (USD Mn)
TABLE 134 Europe CRO market size, by pre-clinical services, 2021 - 2027 (USD Mn)
TABLE 135 Europe CRO market size, by clinical research services, 2016 - 2020 (USD Mn)
TABLE 136 Europe CRO market size, by clinical research services, 2021 - 2027 (USD Mn)
TABLE 137 Europe CRO market size, by laboratory services, 2016 - 2020 (USD Mn)
TABLE 138 Europe CRO market size, by laboratory services, 2021 - 2027 (USD Mn)
TA

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook